Abstract
Introduction Four-Dimensional Computed Tomography (4DCT) shows promise in diagnosing wrist pathologies such as scapholunate ligament lesions (SLL). Two parameters indicative of SLL lesions in these scans, the scapholunate angle (SLA) and the capitolunate angle (CLA), might be affected by anatomical shape variations. Therefore, this study characterizes the impact of anatomical shape variations on SLA and CLA estimates from 4DCT scans.
Methods 3D CT images retrieved from 4DCT scans of healthy wrists were used. Scans were automatically segmented using an Artificial Intelligence-based algorithm. A statistical shape model (SSM) was created for each bone separately. The quality of each SSM was assessed using a leave-one-out approach by calculating the root mean squared error (RMSE). Next, local coordinate systems (LCSs) were assigned to the SSMs while shape variations were introduced. The rotational deviation of the LCSs was calculated by a combined rotation around the three axes. Finally, the SLAs and CLAs were calculated for all possible bone shape combinations.
Results SSMs of the carpal bones and radius were created using 106 and 99 scans, respectively, with a maximum RMSE across all SSMs of 0.65 mm. The 95th percentile of the rotational deviations of the LCSs of the carpal bones and radius were below 3°. The resulting uncertainty due to anatomical variations in the calculation of the SLA and CLA was 2-3°.
Conclusion Anatomical shape variations hardly influence the SLA, CLA, and LCSs of the carpal bones and radius so the methods to estimate the LCSs can be used to estimate relevant kinematic parameters in 4DCT scans.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All subjects gave informed consent for inclusion before participating in the study. The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee METC Oost-Nederland (ABR Number: NL72518.091.19 and NL84487.091.23).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Email addresses all Authors in consecutive order: maranda.haenen{at}radboudumc.nl; stefan.hummelink{at}raboudumc.nl; e.karstanje{at}student.utwente.nl; Ioannis.Sechopoulos{at}radboudumc.nl; brigitte.vanderheijden{at}radboudumc.nl
Ethics Statements: All subjects gave informed consent for inclusion before participating in the study. The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee (ABR Number: NL72518.091.19 and NL84487.091.23)
Data Availability
All data produced in the present study are available upon reasonable request to the authors